Levomefolic acid
Names | |
---|---|
IUPAC name
(2S)-2-[ [4-[(2-Amino-5-methyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl) methylamino]benzoyl]amino]pentanedioic acid
| |
Other names
(L-5-Me-THFA, L-5-Me-H4FA),
anion: L-5-methyltetrahydrofolate (L-5-Me-THF, L-5-Me-H4F), L-methylfolate Metafolin | |
Identifiers | |
| |
3D model (
JSmol ) |
|
ChEBI | |
ChemSpider | |
KEGG | |
MeSH | 5-methyltetrahydrofolate |
PubChem CID
|
|
UNII |
|
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C20H25N7O6 | |
Molar mass | 459.463 g·mol−1 |
Pharmacology | |
B03BB51 (WHO) | |
oral, transdermal, subcutaneous | |
Legal status |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Levomefolic acid (
It is synthesized in the absorptive cells of the small intestine from polyglutamylated dietary
Levomefolic acid is generated by
L-Methylfolate is water-soluble and primarily excreted via the kidneys. In a study of 21 subjects with coronary artery disease, peak plasma levels were reached in one to three hours following
Metabolism
Medical uses
Major depressive disorder
Research suggests that levomefolic acid (L-methylfolate) taken with a
Cardiovascular disease and cancer
Levomefolic acid (and folic acid in turn) has been proposed for treatment of cardiovascular disease
Patent issues
In March 2012,
In September 2012, the same three plaintiffs filed a complaint requesting that the International Trade Commission begin a investigation of the same four defendants. The complaint states that Gnosis' "Extrafolic-S" and products which are made from it, infringe upon three of their patents: US 5997915, US 6673381, and US 7172778.[13]
Formulations
Levomefolate calcium, a calcium salt of levomefolic acid is sold under the brand name Metafolin[14] and incorporated in Deplin.[15] Levomefolate magnesium is a magnesium salt of levomefolic acid, manufactured as DeltaFolate, a primary ingredient in EnLyte.[16]
See also
- 5,10-Methylenetetrahydrofolate
- S-Adenosylmethionine(SAMe)
References
- S2CID 12876272.
- ^ "5-methyltetrahydrofolate – Compound Summary", PubChem, NCBI, retrieved 25 September 2012
- ^ "CerefolinNAC Caplets Package Insert" (PDF).
- ^ Sussman, Norman (1 March 2009). "Selecting a First-line Antidepressant: New Analysis". Primary Psychiatry. 16: 19–22.
- PMID 34794190.
- S2CID 245436052.
- PMID 24372461.
- PMID 14769778.
- ]
- PMID 15870856.
- ^ The six patents named were US 5997915, US 6011040, US 6254904, US 6673381, US 7674490 and US 7172778.
- ^ "Pernix Therapeutics' Subsidiary Macoven Pharmaceuticals, LLC Named in Suit by Merck, Pamlab, L.L.C. and Others for Alleged". Bloomberg. 6 March 2012. Retrieved 1 October 2012.
- ^ Schweibenz EW (10 September 2012). "SAMSF, Merck, and Pamlab File New 337 Complaint Regarding Certain Reduced Folate Nutraceutical Products and L-methylfolate Raw Ingredients Used Therein". Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P. Archived from the original on 1 October 2012.
- ^ "Metafolin". MilliporeSigma. Retrieved 28 November 2022.
Metafolin® is our manufactured calcium salt of L-5-methyltetrahydrofolic or L-methylfolate. ... The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the US and Canada.
- ^ "DEPLIN®". For Healthcare Professionals. Retrieved 28 November 2022.
- ^ "EnLyte with DeltaFolate". dailymed.nlm.nih.gov. Retrieved 28 November 2022.
External links
- Calcium L5-methyltetrahydrofolate (L-5-MTHF-Ca)
- Brockton NT (October 2006). "Localized depletion: the key to colorectal cancer risk mediated by MTHFR genotype and folate?". Cancer Causes & Control. 17 (8): 1005–16. S2CID 20394873.
- Stahl SM (October 2007). "Novel therapeutics for depression: L-methylfolate as a trimonoamine modulator and antidepressant-augmenting agent". CNS Spectrums. 12 (10): 739–44. S2CID 27000937.